Progress Towards Developing an Effective HIV Cure
Steven G. Deeks, MD
Professor of Medicine
University of California, San Francisco
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2020. All rights reserved.
Steve Deeks is a recognized expert on HIV-associated immune dysfunction and its impact on HIV persistence (the “reservoir”) and health during antiretroviral therapy. He has published over 500 peer-review articles, editorials and invited reviews. He has been the recipient of several NIH grants, including an NIH-funded international collaboratory aimed at developing therapeutic interventions to cure HIV infection. In March, 2020, created the “Long-term Impact of Infection with Novel Coronavirus (LIINC)” cohort, now supporting dozens of studies addressing the impact of SARS-CoV-2.
At the completion of this educational session, learners will:
- Discuss why a cure may be needed from an individual and public health perspective.
- Outline the major causes of HIV persistence during therapy.
- Summarize novel therapeutic interventions that are being studied or considered as curative strategies.
- Describe the emerging role of gene modification approaches in HIV cure research.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Download Article PDF/Slides